ArticleBMC nephrology2023

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes - contraindications and opportunities.

C M Gant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.